Clearview Treatment Programs Announces New Collaboration with Yale University
LOS ANGELES (PRWEB) February 13, 2018 -- Clearview Treatment Programs is proud to announce a new collaboration with Yale University. The Yale University School of Medicine, Department of Psychiatry is a world leader in patient care, research, and education.
As part of this relationship, Clearview and Yale will collaborate on the following activities:
Clinical Outcomes:
Clearview will collaborate with experts from the Yale University School of Medicine, Department of Psychiatry, to investigate the clinical effectiveness of Clearview's residential programs. Tracking the outcomes of our clients allows Clearview to study the quality and effectiveness of their programs and improve the treatment provided.
Training:
Clearview's already highly trained staff will receive training and ongoing consultation from leading Dialectical Behavior Therapy (DBT) experts from the Yale University School of Medicine, including Drs. Seth Axelrod, Ph.D. and Emily Cooney, Ph.D. Training will focus on a variety of topics including DBT for disorders of emotional dysregulation, DBT for substance use disorders, increasing fidelity to the DBT model, and enhancing therapists' effectiveness.
Sponsorships:
YIELD, the Yale Instruction/Investigation/Intervention in Emotional Liability and Dysregulation Program - Clearview is a proud sponsor and supporter of YIELD. This vital program provides education about problems of chronic emotional dysregulation to mental health professionals. It also provides education and support to those struggling with mental health disorders and their families.
Annual Yale NEA-BPD Conference - Clearview will also continue to sponsor the Annual Yale NEA-BPD Conference. The National Education Alliance for BPD (NEA-BPD) works to provide education to policy makers and raise public awareness while decreasing stigma and improving the quality of life for those with Borderline Personality Disorder and their loved ones. Each year, these conferences offer the latest in news and cutting-edge research about BPD and provide educational programming and an opportunity for mental health professionals to earn continuing education credits.
Clearview and Yale:
Clearview Treatment Programs is a national leader in the treatment of addictions and mental health disorders, including Borderline Personality Disorder and emotional dysregulation. Clearview is excited to be collaborating with Yale University School of Medicine, Department of Psychiatry. Clearview is confident that working with Yale will provide even deeper insight into the treatment programs offered at Clearview Treatment Programs and enable them to continue to provide the best care possible to their clients.
For any questions about Clearview's treatment programs, please call their recovery specialists at (866) 372-2762.
About Clearview Treatment Programs
Clearview Treatment Programs is a premier provider of treatment for people with Borderline Personality Disorder, psychiatric disorders, addictions, and dual diagnosis. Internationally known for its Dialectical Behavior Therapy (DBT) and evidence-based treatment programs, Clearview offers a full continuum of care.
Clearview provides treatment for drug addiction, alcoholism, and co-occurring mental health disorders (BPD, PTSD, depression, anxiety, bipolar disorder, eating disorders, and more) in co-ed and female only, evidence-based treatment settings. Levels of care include residential, intensive outpatient programs (IOP), day treatment (PHP), and individualized outpatient. For more information, visit http://www.clearviewtreatment.com.
Lori Shannon, Clearview Treatment Programs, http://www.ClearviewTreatment.com, +1 (866) 401-9825, [email protected]
Share this article